Today: 20 May 2026
Allstate stock braces for the open after a 5% drop as CEO sale and broker downgrade hit ALL
14 January 2026
1 min read

Allstate stock braces for the open after a 5% drop as CEO sale and broker downgrade hit ALL

New York, Jan 14, 2026, 07:34 EST — Premarket

  • Shares of Allstate dropped 5.3%, ending Tuesday at $197.65.
  • CEO Thomas Wilson offloaded roughly $3.49 million in shares, following a pre-arranged trading plan, according to a recent filing.
  • TD Cowen downgraded Allstate from “buy” to “hold,” but raised its price target to $231. Benzinga

Shares of Allstate dropped 5.28% on Tuesday, closing at $197.65 on a volume near 4.46 million, per data from the company’s investor site.

The decline comes as Allstate approaches its next earnings report in early February, a key event that could shift outlooks on underwriting and investment returns. The insurer is set to release fourth-quarter results on Feb. 5, with the filing expected the day before.

Rate bets remain in focus. Tuesday’s U.S. inflation figures kept traders guessing on the timing of the next Federal Reserve cut, pushing Treasury yields slightly lower after the release.

A regulatory filing late Tuesday revealed that Chief Executive Thomas Wilson offloaded 16,807 shares on Jan. 12. The sale occurred under a Rule 10b5-1 trading plan established on June 27, 2025.

A 10b5-1 plan is a pre-set trading arrangement allowing insiders to sell shares on a fixed timetable, shielding those transactions from daily news noise. On its own, it doesn’t reveal an executive’s stance on the stock.

TD Cowen cut Allstate to “hold” from “buy” on Monday but bumped up its price target to $231 from $224, according to a report outlining the note. GuruFocus

Tuesday’s drop at Allstate wasn’t unique in the insurance space. Progressive slid 5.25%, with Travelers and Chubb also retreating 3.30% and 1.94%, respectively, according to their most recent closing prices.

Catastrophe risk continues to simmer for property insurers, despite the spotlight often on ratings and insider trades. Munich Re reported that global insured losses from natural disasters hit $108 billion in 2025, cautioning that “a warming world makes extreme weather disasters more likely.” Reuters

The near-term risk remains straightforward: if claims trends or weather losses take a turn for the worse as the quarter ends, or if yields continue to fall, insurers could see their gains vanish fast after a solid rally.

Allstate is set to release its fourth-quarter earnings after 4:15 p.m. ET on Feb. 4, with a conference call scheduled for 9 a.m. ET on Feb. 5.

Stock Market Today

  • Applied Digital, Viasat, CECO Environmental, and HNI Shares Plunge Amid Rising Yields and Oil Prices
    May 20, 2026, 5:35 PM EDT. Applied Digital (APLD), Viasat, CECO Environmental, and HNI stocks suffered sharp declines in afternoon trading due to surging 10-year Treasury yields hitting 4.56%, a one-year high, and rising WTI crude oil prices near $104 per barrel amid geopolitical tensions. The market also reacted negatively to the lack of concrete agreements from the recent U.S.-China summit. Applied Digital remains notable, trading near its 52-week high at $42.53 after signing long-term AI data center deals expected to generate $7 billion in revenue over 15 years, reflecting strong positioning in the growing AI infrastructure sector. The broader sell-off weighed on major indexes, including the S&P 500 and Nasdaq, pulling them back from record highs.

Latest articles

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
Gold price hits another record — what GLD and gold stocks are doing before the open
Previous Story

Gold price hits another record — what GLD and gold stocks are doing before the open

Broadcom stock slides after report China told firms to drop VMware, other foreign cyber tools
Next Story

Broadcom stock slides after report China told firms to drop VMware, other foreign cyber tools

Go toTop